Riskpilot← Back to searchSign inGet full accessMolecule Holding A/S
A/SActiveCVR 15511494Dampfærgevej 27, 5.Activities of holding companies · NACE 6421Est. 1991— employees
Revenue 2024
DKK 62K
-70% vs 2023
EBITDA margin
-237.1%
-607% vs 2023
Equity ratio
88.2%
Financial strength
Net profit 2024
DKK -17K
-111% vs 2023
| Revenue | DKK 62K | -70% |
| EBITDA | DKK -147K | -607% |
| Net profit | DKK -17K | -111% |
| Total assets | DKK 1,6M | -73% |
| Equity | DKK 1,4M | -54% |
| Employees | — | — |
Legal name
Molecule Holding A/S
CVR number
15511494
Legal form
Aktieselskab
NACE code
6421 · Activities of holding companies
Founded
1. oktober 1991
Share capital
DKK 1.000.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af selskabets direktør sammen med et medlem af bestyrelsen eller af formanden sammen med et medlem af bestyrelsen.
Company purpose
Selskabets formål er at varetage sine interesser som aktionær i datterselskabet Molecule
Consultancy A/S, samt at investere i ejendomme og andre virksomheder inden for kommunikation,
handel og service m.v.
Address
Dampfærgevej 27, 5.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -69 | -63 | — | — | — | — | — | 2.707 | 1.641 | 207 | 62 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -69 | -63 | 1.108 | 234 | -398 | 765 | 1.715 | -174 | 1.476 | 29 | -147 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -69 | -63 | 1.108 | 234 | -398 | 765 | 1.715 | -174 | 1.476 | 29 | -147 |
| Net financials | 1.835 | 3.382 | 1.303 | 432 | -124 | 963 | 1.845 | 2.850 | 5 | 115 | 107 |
| Profit before tax | 1.766 | 3.319 | 1.169 | 264 | -404 | 744 | 1.695 | 2.676 | 1.481 | 144 | -40 |
| Tax | -10 | -7 | -17 | -29 | -63 | -53 | -37 | -7 | -35 | -14 | -23 |
| Net profit | 1.776 | 3.326 | 1.186 | 293 | -341 | 797 | 1.732 | 2.683 | 1.516 | 158 | -17 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.666 | 6.248 | 6.138 | 6.526 | 5.304 | 5.361 | 6.062 | 5.796 | 5.524 | 5.708 | 1.567 |
| Equity | 3.064 | 5.594 | 5.083 | 5.376 | 5.035 | 4.232 | 5.964 | 5.677 | 5.398 | 2.993 | 1.382 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 436 | 654 | 1.055 | 1.150 | 269 | 1.129 | 98 | 119 | 126 | 2.715 | 185 |
| Total debt | 436 | 654 | 1.055 | 1.150 | 269 | 1.129 | 98 | 119 | 126 | 2.715 | 185 |
EBITDA margin
-237.1%
This company
15.8%
Market median
-1601% vs market
20142024
Equity ratio
88.2%
This company
38.2%
Market median
+131% vs market
20142024
Return on equity
-1.2%
This company
18.4%
Market median
-107% vs market
20142024
Net profit margin
-27.4%
This company
8.1%
Market median
-438% vs market
20142024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20142024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20142024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ET | Audit | 1991 | — | — |
MV Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
BP Management | Management | 1991 | — | — |
MA Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
RB Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
EG | Audit | 1991 | — | — |
SS Management | Management | 1991 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2007 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2008 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 1991 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 1991 | — | — | |
| Board of Directors | 2007 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 66.7% | 66.7% | 2023 | |
Molecule Holding A/S | Company | 20.0% | 20.0% | 2012 |
GREY NORDIC ApS | Company | 66.7% | 66.7% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Molecule Holding A/S 
MOLECULE CONSULTANCY A/SBoard members of Molecule Holding A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Tronborg Andersen | Audit | 0 companies |
| Morten Vestergren Frederiksen | Chief Executive Officer | 0 companies |
| Bent Peter Birgens | Management | 0 companies |
| Mads Aagaard Winther | Chief Executive Officer | 0 companies |
| Rolf Bach Christensen | Chief Executive Officer | 0 companies |
| Egill Georg Christensen | Audit | 0 companies |
| Susanne Saul Stakemann | Management | 0 companies |
| Carl Erik Kjærsgaard | Chairman | 0 companies |
| Sisse Fjelsted Rasmussen | Board of Directors | 0 companies |
| Elisabeth Marie-Angelique Pierini Lüders | Board of Directors | 0 companies |
| Steffen Pierini Lüders | Chairman | 0 companies |
| Hans Kristen Mørch Gundesen | Board of Directors | 0 companies |
| Nico Schou Sørensen | Board of Directors | 0 companies |
| Reinholdt Schultz | Board of Directors | 0 companies |
| Mette Thorn Sørensen | Board of Directors | 0 companies |
| Johan Bo Bramstoft | Board of Directors | 0 companies |
| Børge Kristian Mannov | Chairman | 0 companies |
| Peter Elley | Board of Directors | 0 companies |
| Mike Welsford | Board of Directors | 0 companies |
| Per Emil Hasselbalch Stakemann | Board of Directors | 0 companies |
| Christina Rindom | Board of Directors | 0 companies |